SALT for liver cirrhosis complications
Part of Digestive system clinical trials.
This trial tests a treatment called SALT for people with cirrhosis from hepatitis B who have serious complications. It aims to see if SALT can help improve outcomes for those who may need a liver transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have a history of hepatitis B infection.
- Imaging tests (like ultrasound or CT) must show signs of liver cirrhosis.
- You must have at least one serious complication of cirrhosis, such as a MELD score between 15 and 40, bleeding from veins in the esophagus or stomach, fluid buildup that doesn't go away, repeated episodes of confusion from liver disease, kidney problems linked to liver disease, or lung problems linked to liver disease.
- You must be able to take care of yourself (PS score 0 or 1) and be willing to sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a treatment called SALT for people with liver cirrhosis and a specific type of liver cancer (HCC) caused by hepatitis B. It aims to help patients whose tumors are limited in size and number.
This study looks at when liver transplant is offered and what outcomes happen in people with cirrhosis who have severe “acute-on-chronic” worsening. It may help doctors decide which patients benefit most from transplant and improve care after listing or not listing.
This trial is testing a new way to screen for liver cancer in people with cirrhosis or chronic hepatitis B. It aims to find cancer earlier so it can be treated more effectively.
This trial tests whether a liver transplant plus salt solution (a special preservation fluid) can help people with colorectal cancer that has spread to the liver but cannot be surgically removed. The goal is to see if this approach can stop cancer growth and improve survival.
This trial tests a new way to transplant livers in teenagers with severe liver disease who cannot get a standard living donor transplant. It aims to see if a special type of transplant (called SALT) can help them get the liver they need.
This trial is testing a new way to see how well patients do after a liver transplant. It includes people with severe cirrhosis, other end-stage liver diseases, or liver cancer.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.